Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.
about
Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s DiseaseA Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicityLRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative studyPGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseEfficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.Molecular chaperone-mediated rescue of mitophagy by a Parkin RING1 domain mutantA chaperome subnetwork safeguards proteostasis in aging and neurodegenerative diseaseDEGAS: de novo discovery of dysregulated pathways in human diseasesMethod designed to respect molecular heterogeneity can profoundly correct present data interpretations for genome-wide expression analysisSPIEDw: a searchable platform-independent expression database web toolGene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.A cross-study transcriptional analysis of Parkinson's disease.Semantic relations for interpreting DNA microarray data.Mesencephalic astrocyte-derived neurotrophic factor reduces cell apoptosis via upregulating HSP70 in SHSY-5Y cells.Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers.Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanismsA searchable cross-platform gene expression database reveals connections between drug treatments and disease.Markov Chain Ontology Analysis (MCOA).Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance.Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's diseaseBiosignatures for Parkinson's disease and atypical parkinsonian disorders patients.Mean Expression of the X-Chromosome is Associated with Neuronal DensityCurrent status and future directions of gene expression profiling in Parkinson's disease.Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.Using the BITOLA system to identify candidate genes for Parkinson's disease.Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease.Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease.Moment based gene set testsEvidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.The cortical and striatal gene expression profile of 100 hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model.An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative DiseasesPostmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain.Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study.NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies.Gene expression in the Parkinson's disease brain.Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.A molecular signature in blood identifies early Parkinson's disease.
P2860
Q21090572-F1CD0237-CBCD-40C0-8B69-A51231B3437EQ24296968-C28AAE9A-D9C9-4A71-B2AD-A08A74EC81DBQ24307455-41A016A1-256D-49A8-AD0C-76F2DAADB2F6Q24597726-6A9F8C31-CC9A-4DF7-9AC3-6887EACC5010Q27304699-2502A85F-7FEC-4636-B562-2044D1811601Q28116653-B8A28087-CC0D-4E4A-8989-9E3DF979C110Q28252463-0DC51EC6-AC5C-450E-A0D2-B7D46C09D786Q28475850-C1631E4F-CB14-4D11-B4F9-C95737789E4AQ28544818-E258BE95-99CF-4424-B01D-897B9A87F9FDQ31143078-6442D315-B65C-4D7E-9DE7-6C1BFE74D56FQ33389138-EBD258EF-ED85-476C-896A-D4BB15850BCCQ33420377-3C52C1BF-B191-4504-AC89-10F55F46C27FQ33547387-8D169BDB-0AB7-42F2-8A7A-744DEA00E98FQ33711374-4BDFC46B-E61E-420E-9160-5B7C89F963E3Q33762589-65899795-34D3-43B2-B131-47469AE41390Q33889585-9CBB2353-A2D3-415C-8DCD-053408A7AA56Q33906476-AFB0F7FE-DC0D-4ED6-B54A-03270C4E3576Q34109658-BF1CE08B-59C1-4D3A-A618-82BDFCB4542EQ34123013-E71A3B8F-0B4C-4503-84EF-D09FF3B76CF0Q34149066-FA9BC316-DED0-4C6B-A155-159CA4CC6051Q34153906-F6E25102-D68F-4307-A3A6-2D1090A50F70Q34202948-A4FB9D3B-5D43-463B-9B20-6E1027F5C41DQ34260081-6FD1524C-7D3B-40B0-BFAA-D116FB7DEC1AQ34405353-F2A5E669-7C3F-4BB5-AC2E-C8EE32A558AFQ34480817-2A729C1E-F02A-4B62-BE31-6AC910A86674Q34612367-9ACB3B0A-F7E5-4A2E-9722-78F1AB9B4B02Q34749363-A6D3EAE3-8109-4206-AB02-6EE2FBC85D13Q35184668-A30471C2-93AD-41FF-B6FE-FC06882E05C0Q35234940-64BC0321-9327-4CB6-AFEB-411403052798Q35290033-9D13C300-F553-4D16-995B-ADED45A9B186Q35619464-5960B9CE-9D46-4CC2-8B3C-325AAB9D15FCQ35667600-37FF5324-2E0D-4F88-A84E-10FA6B9B0DAAQ35738835-CA8E1367-5477-4448-944A-7E769CAF73EDQ35843631-B6C7A39B-A3E9-4615-96ED-297B2EDE5248Q35864260-F8BFB26D-C13F-4292-85B1-9B18C811EAB2Q35884924-F9592970-587E-4862-814C-89F9B8BBCBA1Q36038362-2815F829-0EDA-476B-BB83-BAFB1A661572Q36069691-23E4B832-E2AD-42CB-B5E6-0E244FC91856Q36128123-D055ED72-0B73-4B1A-B8A4-14C7B8E7826BQ36179021-567966F4-B665-4B57-A96D-3C43C2215DDC
P2860
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Whole genome expression profil ...... nigra in Parkinson's disease.
@en
Whole genome expression profil ...... nigra in Parkinson's disease.
@nl
type
label
Whole genome expression profil ...... nigra in Parkinson's disease.
@en
Whole genome expression profil ...... nigra in Parkinson's disease.
@nl
prefLabel
Whole genome expression profil ...... nigra in Parkinson's disease.
@en
Whole genome expression profil ...... nigra in Parkinson's disease.
@nl
P2093
P2860
P1433
P1476
Whole genome expression profil ...... a nigra in Parkinson's disease
@en
P2093
D T Dexter
M B Graeber
R K B Pearce
P2860
P2888
P356
10.1007/S10048-005-0020-2
P50
P577
2006-01-12T00:00:00Z